Marine n-3 polyunsaturated fatty acids: a potential role in the treatment of sarcopenia

Stuart Gray, Mariasole Da Boit

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sarcopenia is the age-related loss of muscle mass that results in a reduction in skeletal muscle function, quality of life and an increased risk of falls. Older muscle has an ‘anabolic resistance’ to both nutrients and exercise, with the precise underlying mechanism still to be elucidated. The n-3 polyunsaturated fatty acids found in fish oil can be incorporated into the membranes of skeletal muscles, where they may have anti-inflammatory effects. This alteration in muscle membrane fatty acid composition may have anabolic effects in aging muscle and, thus, be useful in the treatment of sarcopenia.
Original languageEnglish
Pages (from-to)187-194
Number of pages7
JournalClinical Lipidology
Volume8
Issue number2
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Sarcopenia
Omega-3 Fatty Acids
Muscles
Skeletal Muscle
Anabolic Agents
Membranes
Fish Oils
Anti-Inflammatory Agents
Fatty Acids
Quality of Life
Food

Cite this

Marine n-3 polyunsaturated fatty acids : a potential role in the treatment of sarcopenia. / Gray, Stuart; Da Boit, Mariasole.

In: Clinical Lipidology, Vol. 8, No. 2, 04.2013, p. 187-194.

Research output: Contribution to journalArticle

Gray, Stuart ; Da Boit, Mariasole. / Marine n-3 polyunsaturated fatty acids : a potential role in the treatment of sarcopenia. In: Clinical Lipidology. 2013 ; Vol. 8, No. 2. pp. 187-194.
@article{81620aa299374202b91d65d49e3fe52a,
title = "Marine n-3 polyunsaturated fatty acids: a potential role in the treatment of sarcopenia",
abstract = "Sarcopenia is the age-related loss of muscle mass that results in a reduction in skeletal muscle function, quality of life and an increased risk of falls. Older muscle has an ‘anabolic resistance’ to both nutrients and exercise, with the precise underlying mechanism still to be elucidated. The n-3 polyunsaturated fatty acids found in fish oil can be incorporated into the membranes of skeletal muscles, where they may have anti-inflammatory effects. This alteration in muscle membrane fatty acid composition may have anabolic effects in aging muscle and, thus, be useful in the treatment of sarcopenia.",
author = "Stuart Gray and {Da Boit}, Mariasole",
year = "2013",
month = "4",
doi = "10.2217/clp.13.10",
language = "English",
volume = "8",
pages = "187--194",
journal = "Clinical Lipidology",
issn = "1758-4299",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Marine n-3 polyunsaturated fatty acids

T2 - a potential role in the treatment of sarcopenia

AU - Gray, Stuart

AU - Da Boit, Mariasole

PY - 2013/4

Y1 - 2013/4

N2 - Sarcopenia is the age-related loss of muscle mass that results in a reduction in skeletal muscle function, quality of life and an increased risk of falls. Older muscle has an ‘anabolic resistance’ to both nutrients and exercise, with the precise underlying mechanism still to be elucidated. The n-3 polyunsaturated fatty acids found in fish oil can be incorporated into the membranes of skeletal muscles, where they may have anti-inflammatory effects. This alteration in muscle membrane fatty acid composition may have anabolic effects in aging muscle and, thus, be useful in the treatment of sarcopenia.

AB - Sarcopenia is the age-related loss of muscle mass that results in a reduction in skeletal muscle function, quality of life and an increased risk of falls. Older muscle has an ‘anabolic resistance’ to both nutrients and exercise, with the precise underlying mechanism still to be elucidated. The n-3 polyunsaturated fatty acids found in fish oil can be incorporated into the membranes of skeletal muscles, where they may have anti-inflammatory effects. This alteration in muscle membrane fatty acid composition may have anabolic effects in aging muscle and, thus, be useful in the treatment of sarcopenia.

U2 - 10.2217/clp.13.10

DO - 10.2217/clp.13.10

M3 - Article

VL - 8

SP - 187

EP - 194

JO - Clinical Lipidology

JF - Clinical Lipidology

SN - 1758-4299

IS - 2

ER -